Table 3.
AS2 for the expression of genes in PseudCap (32) functional classes
| Functional category | AS2, % | ||
| RPMI | RPMI/serum | LB | |
| Adaptation and protection | 75 | 75 | 73 |
| Amino acid metabolism and biosynthesis | 84 | 78 | 80 |
| Antibiotic resistance and susceptibility | 79 | 79 | 64 |
| Biosynthesis of cofactor prosthetic groups and carriers | 86 | 84 | 84 |
| Cell division | 94 | 94 | 88 |
| Cell wall LPS capsule | 87 | 91 | 89 |
| Central intermediary metabolism | 80 | 80 | 76 |
| Chaperone and heat shock | 100 | 100 | 94 |
| Chemotaxis | 89 | 67 | 78 |
| Energy metabolism | 75 | 73 | 72 |
| Fatty acid and phospholipid metabolism | 90 | 86 | 86 |
| Membrane | 83 | 80 | 73 |
| Motility | 90 | 81 | 81 |
| Nucleotide biosynthesis and metabolism | 93 | 93 | 75 |
| Protein secretion and export | 93 | 100 | 87 |
| Putative enzyme | 90 | 88 | 86 |
| Secreted factors | 100 | 100 | 67 |
| Transcription, RNA processing and degradation | 91 | 91 | 78 |
| Transcriptional regulator | 73 | 64 | 59 |
| Translation and posttranslational modification | 90 | 88 | 71 |
| Transport small molecules | 84 | 81 | 69 |
| Two-component regulators | 95 | 89 | 68 |
AS2 for the expression of genes in PseudCap (32) functional classes where transcriptomes from RPMI + 5% MHB (RPMI) and RPMI + 5% MHB + 20% human serum (RPMI/serum) outperformed transcriptomes in LB compared to in vivo transcriptomic data from CF sputum samples and chronic wound. The AS2 represents the percentage of genes within 2 SDs of the mean expression levels in CF sputum and chronic wound samples as determined with z-score calculations using the mean of normalized read counts. Functional categories that performed as well or better than the other in vitro models Mops succinate and SCFM2 are bolded.